Targeted deletion of the PEX2 peroxisome assembly gene in mice provides a model for Zellweger syndrome, a human neuronal migration disorder.
about
Pathogenesis of peroxisomal deficiency disorders (Zellweger syndrome) may be mediated by misregulation of the GABAergic system via the diazepam binding inhibitorPeroxisomes in brain development and functionPeroxisomes are required for lipid metabolism and muscle function in Drosophila melanogasterCerebellum development and medulloblastomaMitochondrial alterations caused by defective peroxisomal biogenesis in a mouse model for Zellweger syndrome (PEX5 knockout mouse)Pex13 inactivation in the mouse disrupts peroxisome biogenesis and leads to a Zellweger syndrome phenotypeDefects in myelination, paranode organization and Purkinje cell innervation in the ether lipid-deficient mouse cerebellumPrenatal and postnatal development of peroxisomal lipid-metabolizing pathways in the mouseDisturbed cholesterol homeostasis in a peroxisome-deficient PEX2 knockout mouse modelDocosahexaenoic acid deficit is not a major pathogenic factor in peroxisome-deficient miceGenomic organization, expression analysis, and chromosomal localization of the mouse PEX3 gene encoding a peroxisomal assembly proteinPEX2 is the E3 ubiquitin ligase required for pexophagy during starvation.alpha-Synuclein abnormalities in mouse models of peroxisome biogenesis disorders.Peroxisome biogenesis and peroxisome biogenesis disorders.Drosophila carrying pex3 or pex16 mutations are models of Zellweger syndrome that reflect its symptoms associated with the absence of peroxisomesMechanisms and disturbances of neuronal migration.PEX11 beta deficiency is lethal and impairs neuronal migration but does not abrogate peroxisome functionPeripheral nervous system defects in a mouse model for peroxisomal biogenesis disorders.Genetic and molecular bases of peroxisome biogenesis disorders.PEX13 deficiency in mouse brain as a model of Zellweger syndrome: abnormal cerebellum formation, reactive gliosis and oxidative stress.Lipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models.Transcriptional evidence for the role of chronic venlafaxine treatment in neurotrophic signaling and neuroplasticity including also Glutamatergic [corrected] - and insulin-mediated neuronal processes.Molecular control of neuronal migration.Peroxisomes in dental tissues of the mouse.Genetic-dependency of peroxisomal cell functions - emerging aspects.Deletion of a single allele of the Pex11β gene is sufficient to cause oxidative stress, delayed differentiation and neuronal death in mouse brainPeroxisomes in Different Skeletal Cell Types during Intramembranous and Endochondral Ossification and Their Regulation during Osteoblast Differentiation by Distinct Peroxisome Proliferator-Activated Receptors.Peroxisome deficiency-induced ER stress and SREBP-2 pathway activation in the liver of newborn PEX2 knock-out miceMetabolic and molecular aspects of ethanolamine phospholipid biosynthesis: the role of CTP:phosphoethanolamine cytidylyltransferase (Pcyt2).Peroxisome deficient invertebrate and vertebrate animal modelsPeroxisome biogenesis and human peroxisome-deficiency disorders.Peroxisome deficiency causes a complex phenotype because of hepatic SREBP/Insig dysregulation associated with endoplasmic reticulum stress.LRP1 regulates peroxisome biogenesis and cholesterol homeostasis in oligodendrocytes and is required for proper CNS myelin development and repair.The mouse gene encoding the peroxisomal membrane protein 1-like protein (PXMP1-L): cDNA cloning, genomic organization and comparative expression studies.The peroxisomal import proteins PEX2, PEX5 and PEX7 are differently involved in Podospora anserina sexual cycle.From peroxisomal disorders to common neurodegenerative diseases - the role of ether phospholipids in the nervous system.The neuronal migration defect in mice with Zellweger syndrome (Pex5 knockout) is not caused by the inactivity of peroxisomal beta-oxidation.
P2860
Q21260342-9B6B098E-CA08-4AAD-84B1-465CD5386353Q26774697-3B90FD79-E7CF-4CCF-8443-166855AD3F72Q27322788-270C53E5-DF10-4A6E-8F0E-DB1E5285935EQ28304753-49972113-C1CB-4214-9C5C-F726A011C014Q28360949-79B76D70-7E3A-48D4-924A-649503369F79Q28511106-3F7A372D-8478-43AD-BEED-D6E404CE91CBQ28512474-1FDE675E-CDB5-4204-AEBD-9606B36E5039Q28585694-2C450F35-C9A5-4838-A5D6-BDAA49072AD3Q28586335-262E0B3D-22EC-4549-AD9E-E120AF9E148FQ28589203-150B36AE-0527-499A-B61B-4294BE27243CQ28594738-6D63B509-E24B-4577-8D1D-34C6D5E1E8E9Q29871461-0C0A4F73-9DA4-4F59-9E39-73C7A093004EQ33643679-D09300AB-B068-42F2-BD67-7F423C77211BQ33957100-7CCE9329-D4F1-49AE-8634-05EBB7272F63Q33986080-1041CC96-39F8-41EF-A9DB-45E62BB68762Q34096020-E0E8176B-DE24-4229-8AB5-5559FAFC3015Q34280995-F6840E9B-1EDA-424F-A67F-E7CEF5F30E36Q34308359-B9C55A39-7595-4689-A2C4-F948C83ACA8FQ34362011-5D4F10AE-C5D5-49B8-9F3D-48C630F0F327Q34458791-6AC2B3E8-C8CE-4186-8446-2ACA22D486A6Q34560712-AD5D0573-FB7B-4938-8749-833011B7159CQ34571919-8D5FC791-3A78-465A-B736-D685CFD75705Q34811414-F59746DF-AA62-466F-B5EB-33FE6B673A01Q34975322-584106BC-24E6-444D-B65B-D52D7FD450A9Q35574139-B23466FA-D03E-4422-8172-50731F1FEFACQ35665063-0FC98F1E-E91F-4E57-8FA5-9A2907A76668Q35859116-5EA86005-1C4C-4949-9084-A0696F1AF756Q36004816-7AC97ACA-D297-451E-97B1-FE52081062B9Q36870879-10CC7BE4-B65A-42F2-91EE-EFC00F7004FBQ37334200-08E0A197-9F42-4973-8C9D-78A8B717201EQ37670278-D40A19CD-15FA-415A-AD42-075960842F81Q43167089-6D0B8229-E024-4AC3-8B73-F33B7DA23BCEQ47130977-758C1D06-37BC-4CF6-8AE0-F82A32A27E74Q48022591-55C2FCCC-DA00-4F9E-90C7-0DAFB13EB238Q48084573-4355532F-6032-4047-9973-7460701CE278Q48159157-F2ABB576-D078-442F-ACE2-70ACEF6B532EQ48636627-95A98AB9-934C-4C1C-A1A4-011CA79531A8
P2860
Targeted deletion of the PEX2 peroxisome assembly gene in mice provides a model for Zellweger syndrome, a human neuronal migration disorder.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Targeted deletion of the PEX2 ...... n neuronal migration disorder.
@ast
Targeted deletion of the PEX2 ...... n neuronal migration disorder.
@en
type
label
Targeted deletion of the PEX2 ...... n neuronal migration disorder.
@ast
Targeted deletion of the PEX2 ...... n neuronal migration disorder.
@en
prefLabel
Targeted deletion of the PEX2 ...... n neuronal migration disorder.
@ast
Targeted deletion of the PEX2 ...... n neuronal migration disorder.
@en
P2860
P356
P1476
Targeted deletion of the PEX2 ...... n neuronal migration disorder.
@en
P2093
P2860
P304
P356
10.1083/JCB.139.5.1293
P407
P577
1997-12-01T00:00:00Z